M&A Activity, OEM News, and FDA approvals were popular topics this past week.

Medtronic acquired certain nano surface technology assets and rights to Nanovis’ OsteoSync titanium pads. Medtronic plans to use them to develop its next-generation PEEK interbody fusion devices. Also, people were checking up on ODT’s M&A roundup, listing all of the mergers & acquisitions in the orthopedic industry so far this year.

Exactech released the results of a new cadaveric study. The study compared the company’s knee balancing tech with traditional manual gap measurement methods used with competing systems, like robotics.

A surgeon at Crystal Clinic Orthopedic Center performed the first surgery using Regenity Biosciences’ RejuvaKnee. The procedure was performed on a college-age athlete who suffered from chronic pain following a prior meniscectomy.

Neuvotion has earned U.S. FDA 510(k) clearance for its first product, NeuStim, a non-invasive, surgery-free wearable device. It electrically stimulates muscles dynamically to support hand movement recovery after stroke or spinal cord injury (SCI), and it lets clinicians scan and pinpoint stimulation targets through a touchscreen interface. 

1. Medtronic Acquires Nano Surface Tech Assets from Nanovis
2. Exactech’s Newton Knee Balancing Outperforms Traditional Methods
3. Regenity Biosciences’ RejuvaKnee Used in First Meniscus Repair Surgery
4. FDA OKs Neuromod Tech to Restore Hand Motion After Stroke, Spinal Cord Injury
5. 2025 Orthopedic Device Companies M&A Roundup (Updated 2/12)